Why is Adeia stock plunging today?

Adeia stock is plummeting nearly 19.9% in pre-open trading today to reach $16.56 after the company reported third-quarter 2026 results that fell well short of Wall Street expectations on both the top and bottom lines, and then compounded the disappointment by reducing its full-year revenue forecast. Adjusted earnings per share came in at $0.21 for the quarter, missing the analyst consensus of $0.35 by 40%, while revenue of $80.2 million trailed the $104.38 million estimate by more than 23% and declined sequentially from $96.1 million in the prior quarter. Management attributed the shortfall to the delayed closing of a small number of large, legally complex media licensing agreements, emphasizing that the business had not been lost but that deal execution timelines had shifted.

Adding to the pressure, Adeia cut its full-year 2026 revenue guidance to a range of $375 million to $415 million, down from the prior outlook of $395 million to $435 million — a reduction of $20 million at the midpoint. The company’s newly appointed CEO, Dipti Vachani, delivered the revised outlook on her first earnings call, with CFO Keith Jones noting that the high end of the range remains achievable if the delayed deals close before year-end. Rosenblatt Securities responded today by trimming its price target from $40 to $35 while maintaining a Buy rating, citing confidence in Adeia’s media and semiconductor intellectual property portfolio and management’s discipline in not rushing negotiations to meet quarterly targets.

The broader market offered little comfort but also no meaningful drag — the Nasdaq Composite is up 0.7% in early activity, the S&P 500 is modestly higher, and the Dow Jones is slightly negative, suggesting the selloff is entirely company-specific rather than macro-driven. There were no notable central bank announcements or major economic data releases today that materially affected the technology licensing sector.

The combination of a severe earnings miss, a meaningful guidance reduction, and investor skepticism about deal-timing credibility — analysts on the earnings call pressed management on why the timeline guidance should be trusted after earlier expectations were missed — has created an outsized premarket decline, pushing the stock toward the lower half of its 52-week range of $11.61 to $34.34.